Aligned with the Health Resources and Services Administration (HRSA), goal of the 340B drug pricing program is to enable covered entities such as Federally Qualified Healthcare Clinics (FQHCs) the ability to stretch scarce federal resources as far as possible, reaching more patients and providing more comprehensive services.

​

Being a pioneer in the pharmacy benefit management, Apovia is proud to be advocates in the healthcare system.

​

Apovia is among the upcoming 340B pharamcies in the US.